Oxford Nanopore Technologies
plc
Oxford
Nanopore to Present at the Barclays 26th Annual Global
Healthcare Conference
12 March 2024
Oxford Nanopore Technologies plc
(LSE: ONT) ("Oxford Nanopore"), the company delivering a new
generation of nanopore-based molecular sensing technology, will
participate in the Barclays 26th Annual Global Healthcare
Conference today, 12 March 2024, in Miami, FL.
Gordon Sanghera, Chief Executive
Officer, and Nick Keher, Chief Financial Officer, will participate
in an analyst led fireside chat at 9:00am EDT (1:00pm
GMT).
A live webcast
of the presentation can be accessed at the
company's investor relations page at: https://nanoporetech.com/about-us/investors/reports.
A replay will be available for at least 30 days following the event
via the same link.
[ENDS]
For further information, please
contact:
Oxford Nanopore Technologies plc
Investors:
ir@nanoporetech.com
Media:
media@nanoporetech.com
Teneo (communications adviser to the
Company)
Tom Murray, Olivia Peters
+44 (0) 20 7353 4200
OxfordNanoporeTechnologies@teneo.com
About Oxford Nanopore Technologies plc:
Oxford Nanopore Technologies' goal
is to bring the widest benefits to society through enabling the
analysis of anything, by anyone, anywhere. The company has
developed a new generation of nanopore-based sensing technology
that is currently used for real-time, high-performance, accessible,
and scalable analysis of DNA and RNA. The technology is used
in more than 120 countries, to understand the biology of humans,
plants, animals, bacteria, viruses and environments as well as to
understand diseases such as cancer. Oxford Nanopore's
technology also has the potential to provide broad, high impact,
rapid insights in a number of areas including healthcare, food and
agriculture.
For more information please
visit: www.nanoporetech.com